GENEWERK GMBH
Desconocido
RECOMB: Stem cell based gene therapy for recombination deficient SCID RECOMB
PROTAGENE CGT GMBH
participó en un
H2020:
H2020-SC1-2016-2017
Gene therapy for rare inherited immune disorders has become a clinical reality. Especially for SCID, two major types of SCID (ADA-SCID, X-SC...
2017-11-21 - 2024-12-31 | Financiado
2017-11-21 - 2024-12-31 | Financiado
SCIDNET: DevelopIng Genetic medicines for Severe Combined Immunodeficiency SCID
PROTAGENE CGT GMBH
participó en un
H2020:
H2020-PHC-2014-2015
Severe combined immunodeficiency (SCID) is a devastating rare disorder of immune system development. Affected infants are born without funct...
2015-12-02 - 2019-12-31 | Financiado
2015-12-02 - 2019-12-31 | Financiado
* No se disponen de datos de la empresa actual.